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Abstract
Background: Research on cannabis use has emphasized frequency as a predictor of problems.
Studies of other drugs reveal that frequency relates to psychological and physiological outcomes,
but quantity also plays an important role. In the study of cannabis, quantity has been difficult to
assess due to the wide range of products and means of consumption.
Methods: The present study introduces three new measures of quantity, and examines their
contribution to cannabis-related problems. Over 5,900 adults using cannabis once or more per
month completed an internet survey that inquired about use, dependence, social problems and
respiratory health. In addition to detailing their frequency of cannabis use, participants also
reported three measures of quantity: number of quarter ounces consumed per month, usual
intensity of intoxication, and maximum intensity of intoxication.
Results: Frequency of use, monthly consumption, and levels of intoxication predicted respiratory
symptoms, social problems and dependence. What is more, each measure of quantity accounted
for significant variance in outcomes after controlling for the effects of frequency.
Conclusion: These findings indicate that quantity is an important predictor of cannabis-related
outcomes, and that the three quantity measures convey useful information about use.
Background
Most research on cannabis emphasizes frequency of con-
sumption. For example, three prominent surveys, the
National Epidemiological Survey on Alcohol and Related
Conditions [1], The Epidemiologic Catchment Area [2],
and the National Comorbidity Survey [3] inquire about
the number of joints smoked per day, and how often par-
ticipants used in the past twelve months. Research on
other drugs reveals that frequency serves as an important
predictor of problems, but quantity also plays an impor-
tant role [4-6]. Similarly, tobacco research has determined
that the impact of cigarette smoking on respiratory health
is related to the quantity of tobacco smoked [7,8]. Thus,
whether addressing the psychological or the physiological
outcomes of cannabis use, there is impetus to consider
quantity.
Quantity of cannabis used is an important predictor of
psychosocial outcomes. In a study conducted by Stephens
and colleagues [9] cannabis users meeting the criteria for
dependence typically reported consuming nearly one half
ounce of cannabis per week, and smoking approximately
three joints daily. Thus, in this research population, a pro-
file of heavy use accompanied dependence. Other studies
indicate that frequency alone does not overwhelmingly
account for dependence. For example, the 2003 National
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Survey on Drug Use and Health [10] found over 60% of
daily cannabis users to be non-dependent. Such variance
in dependence among even daily users suggests that other
factors, such as quantity, play a role in dependence.
For those who smoke cannabis, quantity also contributes
to respiratory symptoms. Inhaling cannabis smoke
exposes the lungs to harmful gaseous and particulate mat-
ter [11,12] and is associated with respiratory impairment
[13]. Daily cannabis smoking predicts respiratory symp-
toms comparable to those resulting from cigarette smoke,
such as coughing, increased phlegm and shortness of
breath [14]. Although the risks for lung cancer are mark-
edly higher in cigarette smokers because of nicotine's
tumor-enhancing effects and THC's tumor-inhibiting
ones, the acute and longitudinal effects of cannabis smoke
on respiratory functioning are dose dependent in a way
that suggests that the smoke increases respiratory irrita-
tion [11,15]. In light of such findings on both respiratory
health and psychosocial functioning, it is apparent that
quantity plays an important role in determining the con-
sequences of cannabis use.
While quantity of use is an important factor to consider, it
is rarely measured. For example, of forty-one articles iden-
tified through the PsychInfo literature database that
address cannabis use and psychosocial problems, only
two include a measure of quantity [16,17]. In an effort to
contend with "uncertainties about THC content [18],"
researchers have often defined heavy use as "daily or near
daily use [18]." Addressing quantity more directly, Chen
and colleagues [16] and Grant and Pickering [17] meas-
ured quantity in terms of the number of joints smoked per
day or per smoking occasion. These approaches have been
helpful, and research stands to benefit from incorporating
other direct and indirect measures of quantity.
The assessment of quantity is important for understand-
ing outcomes of cannabis use, but the design of a mean-
ingful measure is not without its challenges. Tobacco use
may be relatively easy to quantify due to cigarette manu-
facturing standards, but there is no standardized cannabis
product. Alcohol researchers have devised a "standard
drink" [19] to measure alcohol consumption comparably
between different beverage types. However, as joint size
varies, THC content varies, and there are many different
products and means of delivery, a "standard drink" meas-
ure may not apply to cannabis. Nevertheless, an estimate
of amount consumed could still help predict problems.
Additionally, as an indirect measure of quantity, an index
of intoxication might also help predict problems.
The present study introduces new measures of quantity
and examines the relation between quantity of cannabis
consumption and problems. As a direct measure of phys-
ical quantity consumed, we inquired about the number of
quarter ounces used per month. Cannabis users may not
be able to report the precise dosage of individual joints,
but are likely to be familiar with the rate at which they
consume quarter ounces, as this unit of weight typically
corresponds with product purchase [20,21]. In addition
to this direct measure, we also measured quantity indi-
rectly by asking about intensity of intoxication. Psychoac-
tive effects are dose-related [22-25] and therefore
intoxication level conveys information about quantity.
We asked individuals to report both their usual and max-
imum levels of intoxication, as each may relate differen-
tially to problems. With these direct and indirect
measures, we were able to examine the independent con-
tributions of frequency and quantity to cannabis-related
outcomes.
Consistent with previous cannabis research [11,26-28],
we hypothesized that frequency would predict respiratory
symptoms, social problems, and dependence. We further
hypothesized that quantity would predict respiratory
symptoms, social problems, and dependence even after
the effects of frequency were taken into account. To exam-
ine the independent contribution of each predictor, as
well as the effects of quantity after controlling for fre-
quency, hierarchical multiple regression analyses were
conducted for each outcome.
Methods
Participants
Data were collected by means of an internet survey. In
order to access a sample of regular cannabis users, partici-
pants were recruited from among the constituency of sev-
eral organizations promoting drug law reform. The
researchers requested The Drug Policy Alliance, The Mari-
juana Policy Project, and The National Organization for
the Reform of Marijuana Laws to notify their membership
of the survey through e-mail. Participants were asked to
forward the survey information to others, and were
entered into a drawing for a cash prize.
Data from 5,987 participants who reported using mari-
juana at least once per month was used for the analyses.
These individuals included 3,884 men and 2,103 women
ranging in age from 18 to 88 years (M = 31.24, SD =
12.33), with an average educational attainment between
some years of college and an associate's degree. Partici-
pants were 89% Caucasian, 5% mixed race, 1% African/
Caribbean descent, 1% Asian, 1% Latino, 1% Native
American, and 2% chose not to specify ethnicity. Approx-
imately 97% of participants were from the United States,
1% were from the regions of Oceania, Western and North-
ern Europe, and the remaining 2% were from a large vari-
ety of countries around the world, not representing any
particular region.Harm Reduction Journal 2008, 5:20 http://www.harmreductionjournal.com/content/5/1/20
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The analysis examining respiratory symptoms included
only those participants who did not have cystic fibrosis or
asthma, and who had never used other inhalant drugs, in
order to reduce the contribution of other factors related to
respiratory health. This analysis was also limited to indi-
viduals whose primary method of cannabis consumption
involved smoking. Therefore, those who reported con-
suming cannabis primarily by eating were excluded. As a
result, data from a subsample of 2,647 participants was
available for the analysis predicting respiratory symp-
toms. These participants were demographically equivalent
to the larger sample.
Procedure
Survey
The local Institutional Review Board approved the survey
and informed consent procedure. Participants were
informed of the nature of the study, and were instructed
that survey items would inquire about their drug use and
quality of life. Informed consent was obtained at the
beginning of the survey.
Measures
Demographic variables of sex and age were significantly
correlated with the outcomes of interest and were there-
fore included in the analyses as covariates.
Frequency
Participants reported how many days per month they
used cannabis.
Quantity
As a direct measure of quantity, participants were asked to
report the number of quarter ounces they used per month,
on average.
Intensity of intoxication
Usual and maximum levels of intoxication were assessed
to indirectly measure quantity of cannabis consumption.
Participants reported the level of high they usually experi-
enced ("Approximately how 'high,' 'buzzed,' 'stoned,' or
intoxicated do you usually get when you use mari-
juana?"), as well as the maximum level of high experi-
enced in the past 90 days ("What's the highest you've been
in the past 90 days?"). To maximize consistency between
individuals' ratings, response options were provided
along a six-point scale describing a range of highs (1 =
'light buzz', 6 = 'very high') [25].
Respiratory symptoms
Six questions that have been used in previous work on
cannabis smokers [12] inquired about respiratory symp-
toms: Do you have a cough? Do you cough up phlegm in
the morning? Are you troubled by shortness of breath
when hurrying on the level ground or walking up a slight
hill? Do you have to walk slower than most people your
own age on the level ground because of breathlessness?
Does your chest sound wheezy or whistling other than
from colds? Do you wake up at night with tightness in
your chest? Participants responded 'yes' or 'no' and symp-
toms were summed to create a composite variable.
Social problems associated with cannabis use
Nineteen items from the Marijuana Problems Scale [29]
assessed the experience of social problems related to can-
nabis use in the past 90 days. Items included such prob-
lems as getting into trouble at work, getting into fights, or
losing friends because of cannabis use. Responses were
made on a six-point scale of severity, anchored at 0 (no
problem) and 5 (serious problem).
Dependence
Dependence symptoms were assessed using a seven-item
measure based on the DSM-IV-TR criteria for substance
dependence [16,30]. In each item, participants were asked
to indicate whether or not they had experienced a particu-
lar dependence symptom within the past 12 months.
Cigarette smoking
Cigarette smoke contributes to similar respiratory symp-
toms as cannabis smoke [14,31]. Therefore, two measures
of cigarette smoking were included as covariates in the
analysis predicting respiratory symptoms. In one item,
participants indicated if they had ever smoked cigarettes.
In a second item, participants reported the average
number of cigarettes they currently smoked per day.
Results
Participants' cannabis use ranged in frequency from 1 to
31 days per month over the past year (M = 22.62, SD =
10.01), with an average monthly consumption of 3/8 of
an ounce (SD = 0.65, range = 0 to 3/4 ounce). A mean of
0.58 respiratory symptoms was reported (SD = 0.96), with
responses ranging from no symptoms to all six symptoms.
Participants reported experiencing an average of 1.37
dependence symptoms (SD = 1.42, range of 0 to 7) over
the past year, and an average of 4.02 cannabis-related
social problems (SD = 1.57, range of 0 to 19) in the past
90 days. The distributions of responses for cannabis-
related problems, quarter ounces consumed per month
and dependence symptoms were skewed. Subsequently,
these variables were transformed to normalize the distri-
bution of responses. Usual and maximum intoxication
levels ranged from the lowest to the highest response
option. The average level of usual intoxication was near
the midpoint (M = 3.70, SD = 1.26), and the average level
of maximum intoxication approached the high end of the
scale (M = 5.09, SD = 1.29).Harm Reduction Journal 2008, 5:20 http://www.harmreductionjournal.com/content/5/1/20
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Hierarchical multiple regression analyses were conducted
to examine the degree to which frequency and quantity of
cannabis use predicted respiratory symptoms, social prob-
lems and dependence symptoms. Separate regression
analyses were conducted for each outcome, with partici-
pants' age, sex, frequency of cannabis use, quantity of con-
sumption, usual high, and maximum high entered as
predictors in each analysis. Additionally, the analysis pre-
dicting respiratory symptoms included measures of ciga-
rette smoking as covariates. Significance levels for the
second and third analyses were corrected to prevent
inflated probability of type I error [32].
In all analyses, age and sex were included as covariates in
step 1. In the analysis predicting respiratory symptoms,
number of cigarettes currently smoked per day, and
whether participants had ever smoked cigarettes were also
included in step 1 as covariates. Next, in all analyses, fre-
quency of use was entered in step 2. Quantity predictors
were then entered individually, to examine their unique
contribution to outcomes. Quantity of monthly con-
sumption was entered in the third step of regression, usual
intoxication level in the fourth, and maximum intoxica-
tion level in the fifth and final step. Inter-item correlations
are provided in Table 1. Results of the regression analyses
indicate that the three quantity variables contributed sig-
nificantly to the prediction of respiratory symptoms,
social problems and dependence, over and above fre-
quency of use.
Respiratory Symptoms
Altogether, the predictors for respiratory symptoms
explained just over 14 % of variance in this outcome. Fre-
quency of use, quarter ounces per month, and usual intox-
ication level were significantly related to respiratory
symptoms, in order of increasing associative strength (see
Table 2). The number of respiratory symptoms reported
increased the more frequently cannabis was smoked, the
greater the quantity smoked, and the greater the usual
level of intoxication. Participants' maximum level of
intoxication was found to be negatively related to respira-
tory symptoms. This finding was unexpected, and further
replication would be necessary before this result could be
interpreted. After controlling for the effects of frequency,
Table 2: Summary of Regression Analysis for Variables Predicting Respiratory Symptoms (N = 1868)
Variable BS E  B β R2 R2-Change
Step 1 0.124 0.107***
Respondent sex 0.219 0.047 0.102***
Respondent age -0.006 0.002 -0.063*
Ever smoked cigarettes 0.115 0.064 0.057
Cigarettes smoked per day 0.028 0.003 0.268***
Step 2 0.134 0.010***
Frequency of use (days per month) 0.194 0.088 0.062*
Step 3 0.140 0.005**
Quarter ounces per month 0.297 0.094 0.087**
Step 4 0.142 0.002*
Usual intoxication intensity 0.073 0.023 0.091**
Step 5 0.144 0.002*
Maximum intoxication intensity -0.059 0.025 -0.074**
F (8,1868) = 39.267, p < 0.001.
Note. *p < 0.05, **p < 0.01, ***p < 0.001
Table 1: Intercorrelations Between Independent Variables (N = 5987)
V a r i a b l e s 1234 5 6 7 8
1. Respondent age ---
2. Respondent sex -0.005 ---
3. Ever smoked cigarettes 0.115** 0.092** ---
4. Number of cigarettes per day 0.254** 0.057** 0.688** ---
5. Frequency of use (days per month) 0.047** -0.021 0.159** 0.180** ---
6. Quarter ounces consumed per month -0.006 -0.014 0.159** 0.238** 0.600** ---
7. Usual intoxication intensity -0.310** -0.082** -0.048** -0.078** 0.052** 0.136** ---
8. Maximum intoxication intensity -0.424** -0.087** -0.021 -0.086** 0.195** 0.168** 0.629** ---
Note. **p < 0.01Harm Reduction Journal 2008, 5:20 http://www.harmreductionjournal.com/content/5/1/20
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each of the three quantity measures accounted for unique
and significant variance in respiratory symptoms. With
the exception of maximum intoxication, all effects were in
the expected direction.
Social Problems
The set of predictors in this analysis accounted for approx-
imately 12% of variance in participants' report of prob-
lems associated with cannabis use. As shown in Table 3,
frequency of consumption and each of the three quantity
measures were positively related to the experience of can-
nabis-related social problems. Those who used cannabis
more often reported a significantly greater number of
social problems associated with cannabis use. After con-
trolling for frequency of use, the effect of quarter ounces
consumed per month was in the predicted direction, but
did not reach conventional significance levels (R2 change =
.001, p = .054). Both usual and maximum intoxication
levels did significantly predict problems, with more
intense 'highs' corresponding with the experience of more
social problems.
Dependence
As shown in Table 4, the independent variables accounted
for approximately 21% of variance in the number of
dependence symptoms reported. Frequency of use and all
three measures of quantity were significantly related to the
endorsement of dependence symptoms. More frequent
use predicted the endorsement of more dependence
symptoms. What is more, each of the three quantity meas-
ures accounted for a significant portion of variance in
dependence symptoms, over and above frequency.
Greater monthly consumption of quarter ounces was
associated with a higher number of dependence symp-
toms, after controlling for the contribution of frequency.
Both usual and maximum intoxication levels were posi-
tively related to the number of dependence symptoms
Table 4: Summary of Regression Analysis for Variables Predicting Dependence (N = 5446)
Variable BS E  B β R2 R2-Change
Step 1 0.097 0.097***
Respondent sex -0.022 0.006 -0.046***
Respondent age -0.005 0.000 -0.265***
Step 2 0.179 0.082***
Frequency of use (days per month) 0.140 0.012 0.183***
Step 3 0.194 0.016***
Quarter ounces per month 0.110 0.012 0.143***
Step 4 0.202 0.008***
Usual intoxication intensity 0.011 0.003 0.058***
Step 5 0.205 0.003***
Maximum intoxication intensity 0.013 0.003 0.070***
F (6,5445) = 233.836, p < 0.001
Note. ***p < 0.001
Table 3: Summary of Regression Analysis for Variables Predicting Social Problems (N = 5828)
Variable BS E  B β R2 R2-Change
Step 1 0.084 0.084***
Respondent sex -0.134 0.037 -0.045***
Respondent age -0.028 0.002 -0.246***
Step 2 0.113 0.029***
Frequency of use (days per month) 0.663 0.073 0.142***
Step 3 0.113 0.001α
Quarter ounces per month 0.078 0.073 0.017
Step 4 0.122 0.008***
Usual intoxication intensity 0.075 0.018 0.067***
Step 5 0.124 0.002**
Maximum intoxication intensity 0.065 0.019 0.058**
F (6,5827) = 136.881, p < 0.001.
Note. **p < 0.01, ***p < 0.001 α p = 0.054Harm Reduction Journal 2008, 5:20 http://www.harmreductionjournal.com/content/5/1/20
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reported, after controlling for frequency and quantity of
quarter ounces consumed.
Summary
The results demonstrate that quantity is an important
indicator of cannabis-related outcomes. The first hypoth-
esis was supported, as frequency was found to be a signif-
icant predictor of respiratory symptoms, social problems
and dependence. The second hypothesis was also sup-
ported. Quantity of cannabis use predicted respiratory
symptoms, social problems and dependence, after con-
trolling for the effects of frequency. Each of the three
quantity measures was positively related to dependence
symptoms. Two of the quantity measures, quantity of
monthly consumption and level of usual intoxication,
were positively associated with respiratory symptoms.
When examining social problems, more intense usual and
maximum intoxication levels significantly predicted a
higher number of problems. In addition to predicting out-
comes over and above frequency, each of the three quan-
tity measures related significantly to outcomes when
controlling for the effects of each other. These findings
indicate that monthly consumption, usual and maximum
intoxication levels not only predict cannabis-related out-
comes, but that each measure conveys distinct informa-
tion.
Discussion
The present study provides evidence that quantity of can-
nabis use is an important predictor of both psychosocial
and physiological outcomes. Variability in products, dos-
age and delivery has posed a challenge to the quantifica-
tion of cannabis use, and past research has typically
focused on frequency. To explore the contribution of
quantity to cannabis-related outcomes, we introduced
three new measures of quantity and examined their rela-
tion to respiratory symptoms, social problems and
dependence.
Quantity was measured directly by inquiring about the
number of quarter ounces participants consumed per
month. As an indirect measure of quantity, we also asked
participants to report their usual and maximum levels of
intoxication. Consistent with the extant literature, fre-
quency of use predicted social problems and dependence,
as well as respiratory symptoms among cannabis smokers.
After controlling for the effects of frequency, quantity of
cannabis use also predicted respiratory symptoms among
smokers, social problems and dependence. Each of the
three quantity measures accounted for significant and
unique variance in outcomes, indicating that monthly
consumption, maximum and typical intoxication levels
each convey distinct information related to outcomes of
cannabis use.
Although the observed effects of frequency were notably
larger than those of quantity, even the relatively small
effects of quantity bear considerable consequence in an
epidemiological context. With over 40% of people in the
United States trying cannabis once or more [33], and a
prevalence of problems in regular users up to 12% [34],
this relatively small effect could relate to a large number
of people. When addressing such important outcomes as
respiratory function, social problems and dependence,
each amount of variance that can be accounted for is ben-
eficial. Given the popularity of cannabis, there is all the
more impetus to understand the dimensions of use that
are relevant to wellbeing.
There are limitations to the interpretation of results due to
sampling methodology. Participants were recruited from
organizations that advocate drug policy reform, and could
have been hesitant to report negative experiences associ-
ated with cannabis use. The occurrence of problems might
therefore be underrepresented in the data. However, a full
range of responses was observed for each outcome, sug-
gesting that participants were likely to have been forth-
coming. Previous research also indicates that substance
use may be reported at least as candidly in Internet surveys
as in paper-based surveys, if not more so [35,36]. There-
fore, the use of web-based survey methodology may have
increased the likelihood of honest self report.
The extent that the present sample represents the larger
population of cannabis users is unclear. Internet survey
methods enable data to be collected from a large, geo-
graphically diverse group of individuals, but respondents
may differ from the population at large. In the present
study, participants were recruited via the Internet, and the
majority of the sample consisted of Caucasian Americans
with some amount of college education. For these rea-
sons, the characteristics of these participants may not gen-
eralize to others of different demographic backgrounds,
those with lower educational attainment, or individuals
who may not have access to the internet. An astute and
anonymous reviewer emphasized that the role of medical
use could prove particularly important in these results. We
failed to assess the role of medicinal use in this study.
Medical users might require relatively large quantities of
cannabis while experiencing few negative side effects like
those assessed here. A responsible medical user could con-
sume large amounts without numerous symptoms of
social problems, dependence, or respiratory irritation.
Thus, the current results may be overestimates of the
potential impact of quantity on problems in medical
users. More importantly, the potential positive effects of
cannabis overall and in relation to quantity do not appear
in these data. Medical users may report greater symptom
relief as quantities increase, or an optimal dose that is nei-
ther too high nor too low. Recreational users may alsoHarm Reduction Journal 2008, 5:20 http://www.harmreductionjournal.com/content/5/1/20
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find that the effects that they appreciate most will vary
with quantity, perhaps with an optimal dose that is nei-
ther too high nor too low. The results on respiratory
effects also suggest that using smaller amounts of higher
quality cannabis could enhance the safety of the plant.
Examining the implications of quantity in more diverse
populations would require different sampling and survey
methods.
Clearly, quantity of cannabis consumed can be an impor-
tant predictor of problems. Further research can employ
the three new measures of quantity to help clarify its role
in outcomes. These single-item indicators each reveal
unique aspects of the amount consumed and contribute
to the prediction of negative consequences. Continued
efforts to examine quantity can have important implica-
tions for prevention and treatment of cannabis-related
problems. As another astute and anonymous reviewer
mentioned, these data support the idea that efforts to
increase the safety of cannabis can emphasize decreasing
amount as well as frequency of consumption. Despite the
challenges to quantification, the present findings suggest
that perhaps researchers and clinicians should not only
ask people how often they smoke; they should also ask
how much they consume and how high they get.
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